SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Cymer (CYMI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zeev Hed who wrote (17335)5/4/1998 5:44:00 PM
From: WTSherman  Read Replies (2) of 25960
 
<<Off topic>> I'm not one to advocate investing in ENMD, but, I think that if the data discussed so far is accurate you will see UNBELIEVABLE pressure placed on everyone involved to accelerate this in ways that have never been seen before. Rest assured that the phase one trials will start within 6-9 months, if they are as positive as the animal tests there will be no holding back the forces that will push this drug forwards. Look at the acceleration that took place with some AIDS drugs in the past three years. The pressure brought to bear there will look like nothing compared to a cancer drug that "cures" cancer.

ENMD is certainly speculation, but, its also probably has the potential to be the biggest home run in the history of pharm's. If Viagra is a $5B drug, then this one would be a $50B drug. Hardly the same class as KTEL.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News